- Home
- DRUG vs IBEX Comparison
DRUG vs IBEX Comparison
Compare DRUG & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- IBEX
- Stock Information
- Founded
- DRUG 2019
- IBEX 2017
- Country
- DRUG United States
- IBEX United States
- Employees
- DRUG N/A
- IBEX N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- IBEX EDP Services
- Sector
- DRUG Health Care
- IBEX Technology
- Exchange
- DRUG Nasdaq
- IBEX Nasdaq
- Market Cap
- DRUG 253.2M
- IBEX 267.7M
- IPO Year
- DRUG N/A
- IBEX 2020
- Fundamental
- Price
- DRUG $36.06
- IBEX $24.37
- Analyst Decision
- DRUG Strong Buy
- IBEX Buy
- Analyst Count
- DRUG 4
- IBEX 2
- Target Price
- DRUG $84.33
- IBEX $25.00
- AVG Volume (30 Days)
- DRUG 50.7K
- IBEX 264.5K
- Earning Date
- DRUG 02-14-2025
- IBEX 02-06-2025
- Dividend Yield
- DRUG N/A
- IBEX N/A
- EPS Growth
- DRUG N/A
- IBEX 37.48
- EPS
- DRUG N/A
- IBEX 2.13
- Revenue
- DRUG N/A
- IBEX $521,725,000.00
- Revenue This Year
- DRUG N/A
- IBEX $6.47
- Revenue Next Year
- DRUG N/A
- IBEX $4.29
- P/E Ratio
- DRUG N/A
- IBEX $11.40
- Revenue Growth
- DRUG N/A
- IBEX 1.66
- 52 Week Low
- DRUG $0.93
- IBEX $13.00
- 52 Week High
- DRUG $79.02
- IBEX $27.83
- Technical
- Relative Strength Index (RSI)
- DRUG 49.87
- IBEX 47.78
- Support Level
- DRUG $31.55
- IBEX $23.82
- Resistance Level
- DRUG $36.25
- IBEX $25.59
- Average True Range (ATR)
- DRUG 2.74
- IBEX 0.89
- MACD
- DRUG 0.01
- IBEX -0.28
- Stochastic Oscillator
- DRUG 66.15
- IBEX 20.52
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.